Colistin-tigecycline versus colistin-imipenem-cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study

Intensive Care Med. 2015 Nov;41(11):2018-9. doi: 10.1007/s00134-015-4010-z. Epub 2015 Aug 12.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Acinetobacter Infections / drug therapy*
  • Acinetobacter Infections / mortality
  • Acinetobacter baumannii / drug effects*
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Cilastatin / administration & dosage
  • Cilastatin / therapeutic use*
  • Cilastatin, Imipenem Drug Combination
  • Colistin / administration & dosage
  • Colistin / therapeutic use*
  • Drug Combinations
  • Drug Resistance, Multiple, Bacterial / drug effects
  • Humans
  • Imipenem / administration & dosage
  • Imipenem / therapeutic use*
  • Minocycline / administration & dosage
  • Minocycline / analogs & derivatives*
  • Minocycline / therapeutic use
  • Pneumonia, Ventilator-Associated / drug therapy*
  • Pneumonia, Ventilator-Associated / microbiology
  • Pneumonia, Ventilator-Associated / mortality
  • Prognosis
  • Retrospective Studies
  • Salvage Therapy
  • Survival Analysis
  • Tigecycline
  • Tunisia / epidemiology

Substances

  • Anti-Bacterial Agents
  • Drug Combinations
  • Cilastatin
  • Tigecycline
  • Imipenem
  • Cilastatin, Imipenem Drug Combination
  • Minocycline
  • Colistin